0       0

33rd Annual North American Cystic Fibrosis Conference


W03 - W03--CLIN: *Pulmonary Advances


Oct 31, 2019 9:45am ‐ Oct 31, 2019 11:05am

Description

This session highlights the current work in CF pulmonary disease. Discussions will include an exploration of oral versus intravenous antibiotic therapy for pulmonary exacerbations, barriers and outcomes of lung transplantation for advanced lung disease, and a look at a single center's experience in extracorporeal membrane oxygenation.

Learning Objectives:

  • Evaluate the efficacy of home monitoring of FEV-1 in identifying pulmonary exacerbations in cystic fibrosis.
  • Examine barriers to and outcomes of lung transplant for advanced lung disease.
  • Analyze outcomes of ECMO prior to lung transplant.

    Workshop Chair(s):

    Workshop Speaker(s):

    You must be logged in and own this session in order to post comments.

    Print Certificate
    Review Answers
    Print Transcript
    Completed on: token-completed_on
    Review Answers
    Please select the appropriate credit type:
    /
    test_id: 
    credits: 
    completed on: 
    rendered in: 
    * - Indicates answer is required.
    token-content
    token-speaker-name image
    token-speaker-name
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    /
    /
    token-index
    token-content